Shanghai visiting professorship for pharmacy researcher

PA 217/09 A University of Nottingham researcher involved in the discovery of new pharmaceuticals has been awarded a visiting professorship by the Shanghai Institute of Materia Medica, Chinese Academy of Science. The Institute is recognised as one of China's leading drug research centres. Dr Shudong Wang took up the post of Associate Professor and Reader in the School of Pharmacy at The University of Nottingham in October 2005. Her current research is focused on the discovery and development of novel kinase inhibitor drugs in a range of therapeutic areas but with particular emphasis on oncology. She has also been very active in using the advanced medicinal chemistry techniques established at The University of Nottingham to study pharmaceutical compounds isolated from Chinese medicinal plants with particular reference to their anti-cancer or cancer prevention applications. Dr Wang has been involved in drug discovery and development since 1997 when she joined Cyclacel Ltd, a biopharmaceutical company based in Scotland. She was soon appointed Head of Chemistry and programme manager for a multi-disciplinary team which successfully delivered several credible drug compounds, some of which are currently at clinic and pre-clinic development stages.